Journal 2020#2

Distribution of Technological Competencies in the Field of the Antidiabetic Drugs Development in the Regions of the Russian Federation



Abstract References

The high level of uncertainty in the Russian pharmaceutical competitive environment creates a necessity of using open data that indicate the degree of the organizationsí technological competencies. The Analysis of the information on the organizationsí localization in the regions allows generating a regional competence profile, which can be used to plan the drugsí production. The study aims to analyse the distribution of technological competencies in the Russian regions by assessing the prospects for locating production sites of foreign and Russian organizations specialising in the antidiabetic drugs development. We hypothesise that the analysis of the distribution of technological competencies in the regions reduces the marketís uncertainty for deciding on the localization of the socially significant industries. The research model is based on the methods of average-weighted, ranking and categorical analysis of the patent and registration data for shaping the regional competence profiles. The implementation of this method of analysing the organizationsí technological competencies is showed on the example of 18 regions that have production sites of antidiabetic drugs. We substantiated the allocation of 5 types of regional profiles, characterised by similar opportunities and threats for new participants in the pharmaceutical market. We revealed that the model of the cooperation behaviour should consider the technological profile at the regional level. At the same time, the model of competitive behaviour to a much lesser extent depends on the regional characteristics of localized production. The methods of constructing the regionís patent and product ratings and their categorization (with allocation of typical behaviour models) allow determining the technological opportunities for increasing the availability and quality of the Russian pharmaceutical products. Moreover, such methods allow identifying the prospects for long-term cooperation with technological leaders at the regional and industrial levels. That is especially important for implementing the concept of the national drug safety and increasing the availability of the socially significant drugs.